FDA Panel Recommends 2 RSV Vaccines for Older Adultsnews2023-03-01T21:29:15+00:00March 1st, 2023|The New York Times|
After Long Delay, Moderna Pays N.I.H. for Covid Vaccine Techniquenews2023-02-23T23:25:31+00:00February 23rd, 2023|The New York Times|
Fabricantes de vacunas se quedaron con 1400 millones USD en anticiposnews2023-02-04T10:00:24+00:00February 4th, 2023|The New York Times|
Covid Vaccine Makers Kept Prepayments for Canceled Shots for Poor Nationsnews2023-02-01T17:44:17+00:00February 1st, 2023|The New York Times|
Covid Vaccines Targeting Omicron Should Be Standard, Panel Saysnews2023-01-26T22:46:39+00:00January 26th, 2023|The New York Times|
The Only H.I.V. Vaccine in Advanced Trials Has Failed. What Now?news2023-01-18T21:26:06+00:00January 18th, 2023|The New York Times|
Medicare Begins to Rein In Drug Costs for Older Americansnews2023-01-14T16:52:43+00:00January 14th, 2023|The New York Times|
Paxlovid para covid: ¿quién debería tomarlo?news2023-01-12T12:54:08+00:00January 12th, 2023|The New York Times|
Countries Need to Make Their Own Vaccines. Why Isn’t the U.S. Embracing This Pandemic Prevention Strategy?news2022-12-06T20:59:36+00:00December 6th, 2022|The New York Times|
How Immunocompromised Experts Will Celebrate Another Pandemic Holidaynews2022-11-22T23:39:31+00:00November 22nd, 2022|The New York Times|
